NUTRIBAND INC. Cost of Revenue
NUTRIBAND INC. (NTRB) reported Cost of Revenue of $255.64 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-04.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-09-04
- NUTRIBAND INC. cost of revenue for the quarter ending 2026-07-31 was $255.64K, a 45.09% decline year-over-year.
- NUTRIBAND INC. cost of revenue for the quarter ending 2026-04-30 was $236.60K, a 43.05% decline year-over-year.
- NUTRIBAND INC. cost of revenue for the quarter ending 2026-01-31 was $311.77K, a 12.53% decline year-over-year.
- NUTRIBAND INC. cost of revenue for the quarter ending 2025-10-31 was $277.55K, a 38.97% decline year-over-year.
- NUTRIBAND INC. cost of revenue for fiscal 2026 was $1.47M, a 5.31% increase from fiscal 2025.
- NUTRIBAND INC. cost of revenue for fiscal 2025 was $1.40M, a 14.14% increase from fiscal 2024.
- NUTRIBAND INC. cost of revenue for fiscal 2024 was $1.22M, a 7.97% decline from fiscal 2023.
- NUTRIBAND INC. cost of revenue for fiscal 2023 was $1.33M, a 44.82% increase from fiscal 2022.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $255.64K 10-Q · filed 2026-09-04 | $492.24K 10-Q · filed 2026-09-04 | $804.01K derived: sum of 3 quarters · filed 2026-09-04 | $1.08M derived: sum of 4 quarters · filed 2026-09-04 | ||||
| 2026-04-30 | $236.60K 10-Q · filed 2026-06-11 | $548.37K derived: sum of 2 quarters · filed 2026-06-11 | $825.92K derived: sum of 3 quarters · filed 2026-06-11 | $1.29M derived: sum of 4 quarters · filed 2026-09-04 | ||||
| 2026-01-31 | $311.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-29 | $589.32K derived: sum of 2 quarters · filed 2026-04-29 | $1.05M derived: sum of 3 quarters · filed 2026-09-04 | $1.47M 10-K · filed 2026-04-29 | ||||
| 2025-10-31 | $277.55K 10-Q · filed 2025-12-11 | $743.12K derived: sum of 2 quarters · filed 2026-09-04 | $1.16M 10-Q · filed 2025-12-11 | $1.52M derived: sum of 4 quarters · filed 2026-09-04 | ||||
| 2025-07-31 | $465.57K 10-Q · filed 2026-09-04 | $881.02K 10-Q · filed 2026-09-04 | $1.24M derived: sum of 3 quarters · filed 2026-09-04 | $1.69M derived: sum of 4 quarters · filed 2026-09-04 | ||||
| 2025-04-30 | $415.45K 10-Q · filed 2026-06-11 | $771.89K derived: sum of 2 quarters · filed 2026-06-11 | $1.23M derived: sum of 3 quarters · filed 2026-06-11 | $1.57M derived: sum of 4 quarters · filed 2026-06-11 | ||||
| 2025-01-31 | $356.44K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-29 | $811.20K derived: sum of 2 quarters · filed 2026-04-29 | $1.15M derived: sum of 3 quarters · filed 2026-04-29 | $1.40M 10-K · filed 2026-04-29 | ||||
| 2024-10-31 | $454.77K 10-Q · filed 2025-12-11 | $796.04K derived: sum of 2 quarters · filed 2025-12-11 | $1.04M 10-Q · filed 2025-12-11 | $1.38M derived: sum of 4 quarters · filed 2025-12-11 | ||||
| 2024-07-31 | $341.27K 10-Q · filed 2025-09-09 | $585.02K 10-Q · filed 2025-09-09 | $928.40K derived: sum of 3 quarters · filed 2025-09-09 | $1.20M derived: sum of 4 quarters · filed 2025-09-09 | ||||
| 2024-04-30 | $243.75K 10-Q · filed 2025-05-30 | $587.13K derived: sum of 2 quarters · filed 2025-05-30 | $856.05K derived: sum of 3 quarters · filed 2025-05-30 | $1.21M derived: sum of 4 quarters · filed 2025-05-30 | ||||
| 2024-01-31 | $343.38K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-28 | $612.30K derived: sum of 2 quarters · filed 2025-04-28 | $968.56K derived: sum of 3 quarters · filed 2025-04-28 | $1.22M 10-K · filed 2025-04-28 | ||||
| 2023-10-31 | $268.92K 10-Q · filed 2024-12-04 | $625.18K derived: sum of 2 quarters · filed 2024-12-04 | $879.82K 10-Q · filed 2024-12-04 | $1.28M derived: sum of 4 quarters · filed 2024-12-04 | ||||
| 2023-07-31 | $356.26K 10-Q · filed 2024-09-03 | $610.90K 10-Q · filed 2024-09-03 | $1.01M derived: sum of 3 quarters · filed 2024-09-03 | $1.36M derived: sum of 4 quarters · filed 2024-09-03 | ||||
| 2023-04-30 | $254.65K 10-Q · filed 2024-05-31 | $652.79K derived: sum of 2 quarters · filed 2024-05-31 | $1.00M derived: sum of 3 quarters · filed 2024-05-31 | $1.31M derived: sum of 4 quarters · filed 2024-05-31 | ||||
| 2023-01-31 | $398.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-01 | $747.41K derived: sum of 2 quarters · filed 2024-05-01 | $1.05M derived: sum of 3 quarters · filed 2024-05-01 | $1.33M 10-K · filed 2024-05-01 | ||||
| 2022-10-31 | $349.27K 10-Q · filed 2023-12-13 | $653.63K derived: sum of 2 quarters · filed 2023-12-13 | $931.06K 10-Q · filed 2023-12-13 | $1.23M derived: sum of 4 quarters · filed 2023-12-13 | ||||
| 2022-07-31 | $304.35K 10-Q · filed 2023-09-11 | $581.79K 10-Q · filed 2023-09-11 | $882.33K derived: sum of 3 quarters · filed 2023-09-11 | $1.09M derived: sum of 4 quarters · filed 2023-09-11 | ||||
| 2022-04-30 | $277.44K 10-Q · filed 2023-06-09 | $577.98K derived: sum of 2 quarters · filed 2023-06-09 | $785.68K derived: sum of 3 quarters · filed 2023-06-09 | $1.00M derived: sum of 4 quarters · filed 2023-06-09 | ||||
| 2022-01-31 | $300.54K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-26 | $508.24K derived: sum of 2 quarters · filed 2023-04-26 | $722.70K derived: sum of 3 quarters · filed 2023-04-26 | $917.84K 10-K · filed 2023-04-26 | ||||
| 2021-10-31 | $207.70K 10-Q · filed 2022-12-02 | $173.69K 10-Q · filed 2021-12-14 | $422.15K derived: sum of 2 quarters · filed 2022-12-02 | $617.30K 10-Q · filed 2022-12-02 | $529.30K 10-Q · filed 2021-12-14 | $824.50K derived: sum of 4 quarters · filed 2022-12-02 | ||
| 2021-07-31 | $214.46K 10-Q · filed 2022-09-08 | $186.76K 10-Q · filed 2021-09-03 | $409.61K 10-Q · filed 2022-09-08 | $355.61K 10-Q · filed 2021-09-03 | $616.79K derived: sum of 3 quarters · filed 2022-09-08 | $845.57K derived: sum of 4 quarters · filed 2022-09-08 | ||
| 2021-04-30 | $195.61K 10-Q · filed 2022-05-31 | $168.84K 10-Q · filed 2021-06-14 | $402.34K derived: sum of 2 quarters · filed 2022-05-31 | $631.11K derived: sum of 3 quarters · filed 2022-05-31 | $748.05K derived: sum of 4 quarters · filed 2022-05-31 | |||
| 2021-01-31 | $206.73K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-29 | $435.50K derived: sum of 2 quarters · filed 2022-04-29 | $552.44K derived: sum of 3 quarters · filed 2022-04-29 | $627.38K 10-K · filed 2022-04-29 | $582.38K 10-K · filed 2021-04-02 | |||
| 2020-10-31 | $228.77K 10-Q · filed 2021-12-14 | $345.71K derived: sum of 2 quarters · filed 2021-12-14 | $420.65K 10-Q · filed 2021-12-14 | $546.88K derived: sum of 4 quarters · filed 2021-12-14 | ||||
| 2020-07-31 | $116.94K 10-Q · filed 2021-09-03 | $191.88K 10-Q · filed 2021-09-03 | $318.10K derived: sum of 3 quarters · filed 2021-09-03 | $424.23K derived: sum of 4 quarters · filed 2021-09-03 | ||||
| 2020-04-30 | $74.94K 10-Q · filed 2021-06-14 | $201.17K derived: sum of 2 quarters · filed 2021-06-14 | $307.29K derived: sum of 3 quarters · filed 2021-06-14 | $425.25K derived: sum of 4 quarters · filed 2021-06-14 | ||||
| 2020-01-31 | $126.23K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-02 | $232.35K derived: sum of 2 quarters · filed 2021-04-02 | $350.31K derived: sum of 3 quarters · filed 2021-04-02 | $549.11K 10-K · filed 2021-04-02 | ||||
| 2019-10-31 | $106.13K 10-Q · filed 2020-12-15 | $224.09K derived: sum of 2 quarters · filed 2020-12-15 | $422.88K 10-Q · filed 2020-12-15 | |||||
| 2019-07-31 | $117.96K 10-Q · filed 2020-09-11 | $316.75K 10-Q · filed 2020-09-11 | ||||||
| 2019-04-30 | $198.79K 10-Q · filed 2019-06-13 | |||||||
| 2019-01-31 | $288.30K 10-K · filed 2019-04-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |